“alzheimers-disease” Archives

in
Entry Author Date Location
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing 10/22/19 Boston
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO 10/01/19 New York
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage 09/13/19 Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs 07/11/19 National
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance 06/04/19 Boston
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Alzheimer’s, Gene Therapy & More: Agenda For “What’s Hot” on May 21 04/16/19 Boston
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival 03/19/19 San Diego
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact 02/22/19 Boston
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials 02/06/19 San Francisco
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data 02/01/19 Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test 01/30/19 National
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease 01/30/19 Boston
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Tetra Inks Deal with Shionogi to Support Fragile X, Alzheimer’s R&D 01/09/19 Detroit Ann Arbor
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs 01/07/19 San Francisco
San Francisco Biotech: The Next Generation—Photos and Takeaways 12/26/18 San Francisco
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer’s 12/12/18 Indiana
Viracta, Neurelis & More: The Latest in San Diego Biotech 12/05/18 San Diego
Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research 11/09/18 San Diego
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum 11/08/18 San Francisco
Page 1 of 6 next page »